News on Neurogen from BioPortfolio.com http://www.BioPortfolio.com Consolidated Neurogen news from BioPortfolio.com Wed, 10 Feb 2010 06:30:16 GMT en Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038960&HITNO=0&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038960&THISHREF=http://c.moreover.com/click/here.pl%3fz2537852243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038960&HITNO=0&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038960&THISHREF=http://c.moreover.com/click/here.pl%3fz2537852243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038931&HITNO=1&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038931&THISHREF=http://c.moreover.com/click/here.pl%3fz2537838958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038931&HITNO=1&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038931&THISHREF=http://c.moreover.com/click/here.pl%3fz2537838958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Chelsea Therapeutics Announces Advancements in Neurogenic Orthostatic Hypotension Registration Programhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036389&HITNO=2&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036389&THISHREF=http://c.moreover.com/click/here.pl%3fz2536596320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036389&HITNO=2&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036389&THISHREF=http://c.moreover.com/click/here.pl%3fz2536596320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: The Effect of Epigenetic Therapy on Congenital Neurogenic Bladders : A Pilot Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034274&HITNO=3&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034274&THISHREF=http://c.moreover.com/click/here.pl%3fz2535694815%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034274&HITNO=3&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034274&THISHREF=http://c.moreover.com/click/here.pl%3fz2535694815%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Chelsea Therapeutics Announces Advancements in Neurogenic Orthostatic Hypotension Registration Programhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034844&HITNO=4&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034844&THISHREF=http://c.moreover.com/click/here.pl%3fz2536010628%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034844&HITNO=4&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034844&THISHREF=http://c.moreover.com/click/here.pl%3fz2536010628%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036884&HITNO=5&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036884&THISHREF=http://c.moreover.com/click/here.pl%3fz2536813000%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036884&HITNO=5&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036884&THISHREF=http://c.moreover.com/click/here.pl%3fz2536813000%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035289&HITNO=6&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035289&THISHREF=http://c.moreover.com/click/here.pl%3fz2536185463%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035289&HITNO=6&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035289&THISHREF=http://c.moreover.com/click/here.pl%3fz2536185463%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035267&HITNO=7&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536176351%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035267&HITNO=7&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536176351%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035246&HITNO=8&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035246&THISHREF=http://c.moreover.com/click/here.pl%3fz2536164492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035246&HITNO=8&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035246&THISHREF=http://c.moreover.com/click/here.pl%3fz2536164492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035243&HITNO=9&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035243&THISHREF=http://c.moreover.com/click/here.pl%3fz2536163912%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035243&HITNO=9&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035243&THISHREF=http://c.moreover.com/click/here.pl%3fz2536163912%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034963&HITNO=10&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034963&THISHREF=http://c.moreover.com/click/here.pl%3fz2536070294%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034963&HITNO=10&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034963&THISHREF=http://c.moreover.com/click/here.pl%3fz2536070294%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034952&HITNO=11&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034952&THISHREF=http://c.moreover.com/click/here.pl%3fz2536063528%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034952&HITNO=11&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034952&THISHREF=http://c.moreover.com/click/here.pl%3fz2536063528%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034925&HITNO=12&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034925&THISHREF=http://c.moreover.com/click/here.pl%3fz2536050493%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034925&HITNO=12&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034925&THISHREF=http://c.moreover.com/click/here.pl%3fz2536050493%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034900&HITNO=13&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034900&THISHREF=http://c.moreover.com/click/here.pl%3fz2536031583%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034900&HITNO=13&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034900&THISHREF=http://c.moreover.com/click/here.pl%3fz2536031583%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Review of the efficacy and safety of transanal irrigation for neurogenic bowel dysfunctionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034264&HITNO=14&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034264&THISHREF=http://c.moreover.com/click/here.pl%3fz2535693827%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034264&HITNO=14&MSIZE=48&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neurogen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034264&THISHREF=http://c.moreover.com/click/here.pl%3fz2535693827%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSpinal Cord Journal: